​

Zymeworks (ZYME) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Zymeworks Revenue Highlights

0

Latest Revenue (Q)

$16.00M

Main Segment (Y)

Milestone Revenue

Zymeworks Revenue by Period

Zymeworks Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$76.01M-81.57%
2022-12-31$412.48M1446.03%
2021-12-31$26.68M-31.50%
2020-12-31$38.95M31.84%
2019-12-31$29.54M-44.28%
2018-12-31$53.02M2.43%
2017-12-31$51.76M370.18%
2016-12-31$11.01M13.96%
2015-12-31$9.66M478.44%
2014-12-31$1.67M-

Zymeworks generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Zymeworks Revenue by Quarter

DateRevenueChange
2024-09-30$16.00M-16.85%
2024-06-30$19.24M91.85%
2024-03-31$10.03M-40.74%
2023-12-31$16.93M2.54%
2023-09-30$16.51M135.73%
2023-06-30$7.00M-80.32%
2023-03-31$35.58M-91.16%
2022-12-31$402.49M15198.10%
2022-09-30$2.63M-51.65%
2022-06-30$5.44M184.03%
2022-03-31$1.92M-90.36%
2021-12-31$19.87M352.10%
2021-09-30$4.39M148.16%
2021-06-30$1.77M175.00%
2021-03-31$644.00K-95.89%
2020-12-31$15.68M493.27%
2020-09-30$2.64M-78.61%
2020-06-30$12.36M49.46%
2020-03-31$8.27M340.54%
2019-12-31$1.88M-76.12%
2019-09-30$7.86M-0.28%
2019-06-30$7.88M-33.90%
2019-03-31$11.93M-58.77%
2018-12-31$28.93M1308.23%
2018-09-30$2.05M-90.66%
2018-06-30$22.00M54900.00%
2018-03-31$40.00K-99.92%
2017-12-31$50.07M41976.47%
2017-09-30$119.00K-91.13%
2017-06-30$1.34M483.48%
2017-03-31$230.00K-89.70%
2016-12-31$2.23M2.76%
2016-09-30$2.17M-65.76%
2016-06-30$6.34M2320.99%
2016-03-31$262.00K-

Zymeworks generated $16.00M in revenue during Q3 2024, up -16.85% compared to the previous quarter, and up 228.51% compared to the same period a year ago.

Zymeworks Revenue Breakdown

Zymeworks Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22
Research Support Payments And Other Service$2.83M$52.62M$8.20M
Royalty$100.00K--
Milestone Revenue$25.00M--
Licensing Fee--$5.00M

Zymeworks's latest annual revenue breakdown by segment (product or service), as of Dec 24: Milestone Revenue (89.49%), Research Support Payments And Other Service (10.15%), and Royalty (0.36%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
Upfront Fee$18.00M$18.00M$18.00M-------
Research Support Payments And Other Service-$764.00K$1.11M$2.07M$10.04M$538.00K$1.16M---
Milestone Revenue-$2.50M$8.00M-------
Milestone Payment--------$1.00M-
License and Service--------$5.50M-
Other Product---------$2.63M

Zymeworks's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Upfront Fee (100.00%).

Zymeworks Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$709.95M$176.57M
BPMCBlueprint Medicines$508.82M$128.18M
TVTXTravere Therapeutics$233.18M$62.90M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
ALECAlector$100.56M$15.08M
YMABY-mAbs Therapeutics$87.69M$18.46M
BLUEbluebird bio$83.81M$16.10M
ZNTLZentalis Pharmaceuticals$67.42M-
MRSNMersana Therapeutics$40.50M$12.60M
STOKStoke Therapeutics$36.55M$4.89M
SNDXSyndax Pharmaceuticals$23.68M$12.50M
CYTKCytokinetics$18.47M$463.00K
RLAYRelay Therapeutics$10.01M-
PRQRProQR Therapeutics$6.38M$4.48M
ARWRArrowhead Pharmaceuticals$3.55M$2.50M
AKROAkero Therapeutics--
EDITEditas Medicine--
PTGXProtagonist Therapeutics-$4.67M
ZYMEZymeworks-$16.00M
CABACabaletta Bio--
RVMDRevolution Medicines--
ANNXAnnexon--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--

ZYME Revenue FAQ

What is Zymeworks’s yearly revenue?

Zymeworks's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $76.01M, representing a decrease of -81.57% compared to 2022. ZYME's yearly revenue for 2022 was $412.48M, representing an increase of 1446.03% compared to 2021.

What is Zymeworks’s quarterly revenue?

Zymeworks's quarterly revenue for Q3 2024 was $16M, a -16.85% decrease from the previous quarter (Q2 2024), and a -3.07% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $19.24M, a 91.85% increase from the previous quarter (Q1 2024), and a 174.82% increase year-over-year (Q2 2023). ZYME's quarterly revenue for Q1 2024 was $10.03M, a -40.74% decrease from the previous quarter (Q4 2023), and a -71.81% decrease year-over-year (Q1 2023).

What is Zymeworks’s revenue growth rate?

Zymeworks's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Zymeworks’s revenue streams?

Zymeworks's revenue streams in c 24 are Research Support Payments And Other Service, Royalty, and Milestone Revenue. Research Support Payments And Other Service generated $2.84M in revenue, accounting 10.15% of the company's total revenue, down -94.61% year-over-year. Royalty generated $100K in revenue, accounting 0.36% of the company's total revenue Milestone Revenue generated $25M in revenue, accounting 89.49% of the company's total revenue

What is Zymeworks’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Zymeworks was Milestone Revenue. This segment made a revenue of $25M, representing 89.49% of the company's total revenue.